ClickBio is a technology company.
ClickBio has raised $500K across 1 funding round.
ClickBio has raised $500K in total across 1 funding round.
ClickBio has raised $500K in total across 1 funding round.
ClickBio's investors include Watershed Growth Ventures.
ClickBio is a biotech company founded in 2015 that designs and manufactures innovative, automation-friendly labware to enhance efficiency in life science research.[1][2] Its products, including deep-well plates, large-volume reservoirs, magnetic devices, and custom solutions, integrate seamlessly with liquid handlers to boost throughput in applications like Next Generation Sequencing (NGS).[1][3] ClickBio serves researchers, biotech firms, CROs, biopharma, and labs focused on genomics, molecular biology, and automation, solving key challenges in lab workflows by accelerating discovery through tailored, high-performance tools.[2][3][4] The company has shown steady growth via its technical team of engineers and scientists, with leadership driving operational excellence since at least 2017.[4]
ClickBio was founded in 2015 in Reno, Nevada, emerging from a need to address automation bottlenecks in biotech labs.[1][2] While specific founders are not detailed in available sources, the company's technical design team comprises mechanical engineers and scientists with hands-on lab experience, enabling a deep understanding of research operations.[2] Early focus centered on custom labware for NGS and automation, with pivotal growth marked by team expansions, including operations leader Jessica joining in 2017 to drive patent-protected projects and business development.[4] A 2020 mention in BioCentury alongside major biotech deals highlights early industry recognition.[1]
ClickBio stands out in the labware market through these key strengths:
ClickBio rides the wave of lab automation and high-throughput biotech, fueled by surging demand for NGS, genomics, and personalized medicine amid post-pandemic R&D acceleration.[1][3] Timing aligns with market forces like rising automation adoption in biopharma and CROs to cut costs and speed discovery, where inefficient labware has long been a bottleneck.[2] By enabling seamless integration with robotic systems, ClickBio influences the ecosystem through faster workflows, supporting trends in AI-driven drug discovery and scalable sequencing that broader players like major pharmas depend on.[1][4] Its Reno base positions it in a growing biotech hub, amplifying impact on startup and enterprise labs alike.
ClickBio is primed to expand as lab automation demand intensifies, with custom solutions positioning it for deeper penetration in NGS and robotics markets.[2][3] Upcoming trends like AI-optimized workflows and sustainable lab tech will shape its path, potentially through new product lines or partnerships with sequencing giants. Its influence could evolve from niche innovator to ecosystem enabler, scaling via team-driven growth and riding biotech funding waves—much like its early BioCentury spotlight signaled.[1][4] This automation edge keeps ClickBio accelerating human discovery at pace.
ClickBio has raised $500K across 1 funding round. Most recently, it raised $500K Seed in January 2018.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 1, 2018 | $500K Seed | Watershed Growth Ventures |